Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 4/20 | 0.45 |
| ▸ | TACR2 | P21452 | 3/20 | 0.45 |
| ▸ | TACR1 | P25103 | 3/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | CCR2 | P41597 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL371169 | 0.85 | TACR3 (0.51) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL297581 | 0.83 | TACR3 (0.45) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL370294 | 0.83 | TACR3 (0.48) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL296888 | 0.83 | TACR3 (0.45) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL296395 | 0.80 | TACR3 (0.45) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL296221 | 0.80 | TACR3 (0.68) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL8032648 | 0.79 | TACR3 (0.53) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL296394 | 0.78 | TACR3 (0.50) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL296889 | 0.78 | TACR3 (0.52) | TACR3TACR2TACR1KCNH2CACNA1I | |
| SCHEMBL297161 | 0.77 | TACR2 (0.61) | TACR3TACR2TACR1KCNH2CACNA1I |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200982-B1 | PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2012-03-14 | — | — | EP | disclosed |